P772_H773insYNP P772_V774insPHV Y69FS*11 3' UTR MUTATION AUTOCRINE ACTIVATION G465R G719 K757R V769_770insASV L861Q L861 V774M EGFR 基因突变 OVEREXPRESSION Allele Registry ID:别名: ClinVar ID: 基因突变位点 Ref. Build: GRCh37 Ensembl Version: 75 Chr. Start Stop Ref. s Var. Bases...
A subset of triple-negative breast cancer is known to overexpress epidermal growth factor receptor (EGFR); however prognostic significance of this biomarker has not been widely studied in our population. Therefore, we aimed to evaluate the frequency of EGFR overexpression in triple-negative breast ...
英文标题:Adjuvant Aumolertinib in Patients with Completely Resected, Stage IA2-IIIA Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations 中文标题:阿美替尼辅助治疗伴罕见EGFR突变的完全切除的IA2-IIIA期NSCLC 讲者:H. Ye(...
Overexpression of Her 1 ( EGFR ) in Gastric Cancer : A Saudi Regional Population Based Study * Overexpression of Her 1 ( EGFR ) in Gastric Cancer : A Saudi Regional Population Based Study * GastricCancerEGFROverexpressionImmunocytochemistryProteinAnalysis... A Ahmed,D Tamimi - 病理学期刊(英文) ...
Epidermal growth factor receptor (EGFR) is frequently overexpressed in TNBC. We studied the activity of EGFR antagonists alone, and in combination with ... Corkery,B.,Crown,... - 《Annals of Oncology》 被引量: 425发表: 2009年 EGFR overexpression in malignant pleural mesothelioma. An immunohisto...
Erlotinib, an EGFR tyrosine kinase inhibitor, is used for treating patients with cancer exhibiting EGFR overexpression or mutation. However, the response rate of erlotinib is low among patients with gastric cancer (GC). The ...
G465R G719 K757R V769_770insASV L861Q L861 V774M EGFR 基因突变 EXON 18 OVEREXPRESSION Allele Registry ID:别名: ClinVar ID: 基因突变位点 Ref. Build: GRCh37 Ensembl Version: 75 Chr. Start Stop Ref. s Var. Bases 7 55237999 55238735 Transcript ENST00000344576.2 基因序列移动...
Tyrosine kinase inhibitors (TKIs) have dramatically changed the clinical prospects of patients with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR)-activating mutations. Despite prolonged disease control and high tumor respon
We have examined the expression of the (EGFr) gene and 14 other oncogenes in several . EGFr overexpression was apparent in 17 of 18 tumors. Nevertheless, remarkable amounts of aberrantly-sized EGFr were not found in the 11 tumors examined. Among the 14 other oncogene probes employed, only ...
HER2‐positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy[J]. Int J Cancer,... SY ...